181 related articles for article (PubMed ID: 8192930)
1. [Effect of lymphokine-activated killer cells of head and neck tumors in vitro and in nude mice].
Duan DS
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(5):281-3, 314. PubMed ID: 8192930
[TBL] [Abstract][Full Text] [Related]
2. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Sacchi M; Snyderman CH; Heo DS; Johnson JT; d'Amico F; Herberman RB; Whiteside TL
Cancer Res; 1990 May; 50(10):3113-8. PubMed ID: 2334906
[TBL] [Abstract][Full Text] [Related]
3. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activity of adherent LAK cells (A-LAK) in a model of squamous carcinoma of the head and neck].
Sacchi M; Galeazzi E; Johnson JT; Cavalot AL; Cortesina G
Acta Otorhinolaryngol Ital; 1991; 11(4):405-15. PubMed ID: 1792895
[TBL] [Abstract][Full Text] [Related]
5. [Interleukin-2 and LAK cells in the local immunotherapy of tumors of the head and neck: an experimental model].
Sacchi M; Johnson JT; Whiteside TL; Cortesina G
Acta Otorhinolaryngol Ital; 1989; 9(4):391-8. PubMed ID: 2618654
[TBL] [Abstract][Full Text] [Related]
6. [Anti-human lung giant cell cancer (PG) effect of human LAK cells in vitro and in nude mice].
Deng HY
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):258-60. PubMed ID: 2272258
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL
J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined adoptive immunotherapy and radiotherapy on tumor growth.
Sumareva R; Ukrainsky G; Kiremidjian-Schumacher L; Roy M; Wishe HI; Steinfeld AD; Cooper JS
Radiat Oncol Investig; 1999; 7(1):22-9. PubMed ID: 10030620
[TBL] [Abstract][Full Text] [Related]
9. A murine model for the immunotherapy of head and neck squamous cell carcinoma.
Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE
Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
11. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
[TBL] [Abstract][Full Text] [Related]
12. [Effect of LAK cells and BRM on the growth of pancreatic cancer cells injected into nude mice].
Asano H; Kobari M; Yusa T; Kawakami K; Matsuno S
Nihon Geka Gakkai Zasshi; 1994 Sep; 95(9):678-88. PubMed ID: 7838109
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of LAK cells on CDDP resistant head and neck carcinoma cell line].
Kumazawa H; Hori Y; Tachikawa T; Sai S; Kita J; Yamashita T; Kumazawa T; Kawamoto K
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1843-7. PubMed ID: 8379677
[TBL] [Abstract][Full Text] [Related]
14. [The anti-pancreatic cancer efficacy of LAK cells mediated by YPC3 monoclonal antibody in vitro and in vivo].
Chen QK; Yuan SZ
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):353-5. PubMed ID: 7895586
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killing of autologous and allogeneic short-term cultured head and neck squamous carcinomas.
Leess FR; Bredenkamp JK; Lichtenstein A; Mickel RA
Laryngoscope; 1989 Dec; 99(12):1255-61. PubMed ID: 2601539
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of antitumor activity of tumor draining lymph node lymphocytes and peripheral blood lymphocytes in human oral cancer].
Guo W; Qiu WL; He RG
Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Nov; 29(6):336-8, 384. PubMed ID: 7743875
[TBL] [Abstract][Full Text] [Related]
17. [Cytotoxicity of lymphokine-activated killer cells in conjunction with pingyangmycin to human tongue carcinoma (Tca8113) in vitro and vivo].
Duan JG
Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Jul; 28(4):231-3. PubMed ID: 7513629
[No Abstract] [Full Text] [Related]
18. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
20. [Effect of lymphokine activated killer from umbilical blood on human ovarian cancer in nude mouse models].
He YD; Peng ZL; Liu SL; Wang H; Pan XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):810-2. PubMed ID: 17953364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
